A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient’s Suitability for Immune Checkpoint Inhibition

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient’s Suitability for Immune Checkpoint Inhibition

Michael Wessolly,1,2,* Susann Stephan-Falkenau,3,* Anna Streubel,3 Robert Werner,3 Sabrina Borchert,1,2 Sergej Griff,3 Elena Mairinger,1 Robert FH Walter,1,4 Torsten Bauer,5 Wilfried EE Eberhardt,4,6 Torsten G Blum,5 Kurt W Schmid,1 Jens Kollmeier,5 Thomas Mairinger,1,* Fabian D Mairinger1,2,* 1Inst...

Full description

Bibliographic Details
Main Authors: Wessolly M, Stephan-Falkenau S, Streubel A, Werner R, Borchert S, Griff S, Mairinger E, Walter RFH, Bauer T, Eberhardt WEE, Blum TG, Schmid KW, Kollmeier J, Mairinger T, Mairinger FD
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Cancer Management and Research
Subjects:
massive parallel sequencing
nsclc
immunotherapy
epitope
processing escape
deep learning
Online Access:https://www.dovepress.com/a-novel-epitope-quality-based-immune-escape-mechanism-reveals-patientr-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/a-novel-epitope-quality-based-immune-escape-mechanism-reveals-patientr-peer-reviewed-article-CMAR

Similar Items